STOCK TITAN

[Form 4] AEHR TEST SYSTEMS Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Aehr Test Systems (AEHR) President and CEO, also a director, reported a routine Form 4 transaction. On 10/27/2025, 819 shares of common stock were withheld at $25.14 under code “F” to satisfy tax obligations upon RSU vesting; this is not a market sale.

Following the transaction, beneficial ownership stands at 261,095 shares direct and 291,628 shares indirect by trust. The reported amounts include shares subject to unvested restricted stock units and unvested restricted shares.

Aehr Test Systems (AEHR) Presidente e CEO, nonché consigliere, ha riferito una normale operazione Form 4. Il 27/10/2025, 819 azioni ordinarie sono state trattenute a 25,14 USD nell'ambito del codice “F” per soddisfare gli obblighi fiscali al vesting delle RSU; ciò non costituisce una vendita sul mercato.

Dopo l'operazione, la titolarità beneficiante ammonta a 261.095 azioni dirette e 291.628 azioni indirette tramite trust. Gli importi riportati includono azioni soggette a RSU non maturate e azioni non maturate vincolate.

Aehr Test Systems (AEHR) Presidente y CEO, también director, informó una operación de Form 4 de rutina. El 27/10/2025, se retuvieron 819 acciones ordinarias a 25,14 USD bajo el código “F” para satisfacer obligaciones fiscales al vesting de RSU; esto no es una venta en el mercado.

Después de la operación, la titularidad beneficiosa se sitúa en 261.095 acciones directas y 291.628 acciones indirectas por fideicomiso. Los montos reportados incluyen acciones sujetas a RSU no vesting y acciones restringidas no vestidas.

Aehr Test Systems (AEHR)의 사장 겸 CEO이자 이사인 인물이 정례 Form 4 거래를 보고했습니다. 2025년 10월 27일, RSU의 베스팅에 따른 세금 의무를 충당하기 위해 코드 “F”에 따라 25.14달러로 819주를 원천징수했습니다; 이는 시장 매도가 아닙니다.

거래 후 실질적 소유는 직접 보유 261,095주 및 트러스트를 통해 간접 보유 291,628주입니다. 보고된 수치는 미 베스팅 RSU와 미 베스팅 제한 주식이 포함됩니다.

Aehr Test Systems (AEHR) Président et PDG, également administrateur, a signalé une transaction Form 4 de routine. Le 27/10/2025, 819 actions ordinaires ont été retenues à 25,14 USD dans le cadre du code “F” pour satisfaire les obligations fiscales liées au vesting des RSU; ce n'est pas une vente sur le marché.

Après la transaction, la propriété bénéficiaire se situe à 261 095 actions directes et 291 628 actions indirectes par entité fiduciaire. Les montants déclarés incluent les actions soumises à des RSU non acquises et des actions restreintes non acquises.

Aehr Test Systems (AEHR) Präsident und CEO, zugleich Aufsichtsrat, meldete eine routinemäßige Form-4-Transaktion. Am 27.10.2025 wurden 819 Stammaktien zu 25,14 USD unter dem Code „F“ einbehalten, um Steuerschulden aufgrund der RSU-Vesting zu decken; dies ist kein Marktverkauf.

Nach der Transaktion beläuft sich das wirtschaftliche Eigentum auf direkt 261.095 Aktien und indirekt 291.628 Aktien durch Treuhandvermögen. Die gemeldeten Beträge umfassen Aktien, die RSU-eigenen Nicht-Vesting und unvested Restricted Shares unterliegen.

Aehr Test Systems (AEHR) رئيس مجلس الإدارة والرئيس التنفيذي، وأيضاً عضو مجلس إدارة، بلاغ عن عملية Form 4 روتينية. في 27/10/2025، تم حجز 819 سهماً عادياً بسعر 25.14 دولاراً بموجب الرمز “F” لتلبية الالتزامات الضريبية عند vesting RSU؛ هذا ليس بيعاً في السوق.

بعد الصفقة، تبلغ الملكية الفعلية 261,095 سهماً مباشرة و291,628 سهماً غير مباشر عبر الثقة. تشمل المبالغ المبلّغ عنها أسهماً خاضعة لـ RSU غير مكتسبة وأسهم مقيدة غير مكتسبة.

Positive
  • None.
Negative
  • None.

Aehr Test Systems (AEHR) Presidente e CEO, nonché consigliere, ha riferito una normale operazione Form 4. Il 27/10/2025, 819 azioni ordinarie sono state trattenute a 25,14 USD nell'ambito del codice “F” per soddisfare gli obblighi fiscali al vesting delle RSU; ciò non costituisce una vendita sul mercato.

Dopo l'operazione, la titolarità beneficiante ammonta a 261.095 azioni dirette e 291.628 azioni indirette tramite trust. Gli importi riportati includono azioni soggette a RSU non maturate e azioni non maturate vincolate.

Aehr Test Systems (AEHR) Presidente y CEO, también director, informó una operación de Form 4 de rutina. El 27/10/2025, se retuvieron 819 acciones ordinarias a 25,14 USD bajo el código “F” para satisfacer obligaciones fiscales al vesting de RSU; esto no es una venta en el mercado.

Después de la operación, la titularidad beneficiosa se sitúa en 261.095 acciones directas y 291.628 acciones indirectas por fideicomiso. Los montos reportados incluyen acciones sujetas a RSU no vesting y acciones restringidas no vestidas.

Aehr Test Systems (AEHR)의 사장 겸 CEO이자 이사인 인물이 정례 Form 4 거래를 보고했습니다. 2025년 10월 27일, RSU의 베스팅에 따른 세금 의무를 충당하기 위해 코드 “F”에 따라 25.14달러로 819주를 원천징수했습니다; 이는 시장 매도가 아닙니다.

거래 후 실질적 소유는 직접 보유 261,095주 및 트러스트를 통해 간접 보유 291,628주입니다. 보고된 수치는 미 베스팅 RSU와 미 베스팅 제한 주식이 포함됩니다.

Aehr Test Systems (AEHR) Président et PDG, également administrateur, a signalé une transaction Form 4 de routine. Le 27/10/2025, 819 actions ordinaires ont été retenues à 25,14 USD dans le cadre du code “F” pour satisfaire les obligations fiscales liées au vesting des RSU; ce n'est pas une vente sur le marché.

Après la transaction, la propriété bénéficiaire se situe à 261 095 actions directes et 291 628 actions indirectes par entité fiduciaire. Les montants déclarés incluent les actions soumises à des RSU non acquises et des actions restreintes non acquises.

Aehr Test Systems (AEHR) Präsident und CEO, zugleich Aufsichtsrat, meldete eine routinemäßige Form-4-Transaktion. Am 27.10.2025 wurden 819 Stammaktien zu 25,14 USD unter dem Code „F“ einbehalten, um Steuerschulden aufgrund der RSU-Vesting zu decken; dies ist kein Marktverkauf.

Nach der Transaktion beläuft sich das wirtschaftliche Eigentum auf direkt 261.095 Aktien und indirekt 291.628 Aktien durch Treuhandvermögen. Die gemeldeten Beträge umfassen Aktien, die RSU-eigenen Nicht-Vesting und unvested Restricted Shares unterliegen.

Aehr Test Systems (AEHR) رئيس مجلس الإدارة والرئيس التنفيذي، وأيضاً عضو مجلس إدارة، بلاغ عن عملية Form 4 روتينية. في 27/10/2025، تم حجز 819 سهماً عادياً بسعر 25.14 دولاراً بموجب الرمز “F” لتلبية الالتزامات الضريبية عند vesting RSU؛ هذا ليس بيعاً في السوق.

بعد الصفقة، تبلغ الملكية الفعلية 261,095 سهماً مباشرة و291,628 سهماً غير مباشر عبر الثقة. تشمل المبالغ المبلّغ عنها أسهماً خاضعة لـ RSU غير مكتسبة وأسهم مقيدة غير مكتسبة.

Aehr Test Systems (AEHR) 总裁兼首席执行官,同时也是董事,报告了一笔常规的 Form 4 交易。2025年10月27日,在 RSU 授权归属时,为履行税务义务按代码“F”扣留了 819 股普通股,价格为 25.14 美元;这不是市场出售。

交易完成后,实益拥有为直接持有 261,095 股,间接通过信托持有 291,628 股。报告的数量包括尚未归属的受限股票单位(RSU)和未归属的受限股票。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Erickson Gayn

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/27/2025 F 819(1) D $25.14 261,095(2) D
Common Stock 291,628 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.
2. The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
Remarks:
/s/Chris Siu, Attorney-in-Fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AEHR’s CEO report on Form 4?

An “F” code transaction where 819 shares were withheld to cover taxes upon RSU vesting at $25.14 on 10/27/2025.

Was this a sale of AEHR shares?

No. The filing states the shares were withheld for tax obligations; it does not represent a sale by the reporting person.

How many AEHR shares does the CEO own after the transaction?

Beneficial ownership is 261,095 shares direct and 291,628 shares indirect by trust.

What does transaction code “F” mean in this context?

It indicates share withholding to satisfy tax withholding obligations upon vesting of restricted stock units.

Do the reported holdings include unvested awards?

Yes. The amount reported includes shares subject to unvested RSUs and unvested restricted shares.

What is the issuer and ticker in this filing?

The issuer is Aehr Test Systems with ticker AEHR.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

754.37M
28.21M
5.31%
60.66%
18.86%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT